ホルター心電図解析システムとソフトウェアの世界市場-2024～2031年

概要

世界のホルター心電図解析システムとソフトウェア市場は、2023年に12億4,000万米ドルに達し、2031年には28億4,000万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは10.9％で成長します。

ホルター心電図解析システムは、心臓の電気的活動を24～48時間にわたって継続的にモニターする医療ツールです。患者の胸部の電極を通じてリアルタイムのECGデータを取得し、標準的なECGでは検出されない可能性のある心臓の不整脈を特定して分析します。Hillrom社やPhilips社が開発した最新のホルターシステムは、データ解析とレポート作成に高度なソフトウェアを使用しているため、ヘルスケアプロバイダーは遠隔地から記録をインポートしたり、電子レポートを安全にエクスポートしたりすることができ、HIPAA規制を確実に遵守することができます。注目すべき機能には、スキャンモード、双方向インターフェース、診断精度を向上させる高度な信号処理アルゴリズムなどがあります。

市場力学：

促進要因と阻害要因

ウェアラブルコンポーネントとの統合の拡大

世界のホルター心電図解析システムとソフトウェア市場は、ウェアラブルコンポーネントとの統合の増加によって牽引されています。健康志向の消費者は、フィットネスや健康モニタリングのためにウェアラブルデバイスを使用するようになっており、患者が他の健康指標とともに心臓の健康状態をモニタリングできるようにすることで、ユーザーエクスペリエンスを向上させています。このような融合は、デジタルヘルスエコシステムにおけるホルターモニタリングシステムの認知度を高めるだけでなく、患者の関与を高め、モニタリングプロトコルの遵守を促進します。患者がより積極的に自分の健康を管理するようになるにつれて、高度なホルターモニタリングソリューションに対する需要が高まり、市場の成長が促進されると予想されます。

例えば、デジタルヘルスケアの主要企業であるiRhythm Technologiesは2024年8月、オーストリア、オランダ、スペイン、スイスでZioモニターと長期継続的（LTCM）外来ECGモニタリングサービスを開始しました。ZioモニターとZEUSシステムは2023年12月に医療機器規制のCEマークを取得しました。LTCMサービスは最長14日間の継続的で中断のない心電図モニタリングを提供するもので、これらの国々では旧来のホルターモニタリングサービスと比較して大きな進歩を遂げています。

低い償還政策

ホルター心電図解析システムとソフトウェアの世界市場は、ホルターモニタリング手技に対する低報酬政策による大きな課題に直面しています。多くの地域、特に発展途上諸国では、ホルターモニタリングに対する保険適用は限られているか、存在しないため、ヘルスケアプロバイダーや患者にとって経済的な障壁となっています。このため、ホルターモニタリングシステムの導入が抑制され、多くの施設が費用のかからない代替品や従来の方法を選択するようになります。経済的な制約があるため、ホルターモニタリングシステムの価値提案を再評価し、効果的な心臓ケアと管理に不可欠であるという認識を確保する必要があります。

このレポートの詳細- サンプル請求

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • ウェアラブルコンポーネントとの統合の拡大
• 抑制要因
  • 低い償還ポリシー
• 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• ワイヤレス心電図モニター
• 有線心電図モニター
• ポータブル心電図モニター
• 携帯型心電図モニター

第7章 用途別

• 不整脈
• 心房細動
• 徐脈と頻脈
• 虚血性心疾患
• その他

第8章 エンドユーザー別

• 病院
• 外来手術センター（ASC）
• 心臓センター
• クリニック
• ホームケア設定

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• GE Healthcare
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Philips Healthcare
• VitalConnect
• Vivalink
• Cardioline SpA
• Schiller AG
• Midmark Corporation
• Nasiff Associates, Inc.
• Biomedical Instruments Co., Ltd
• iRhythm Technologies, Inc.（LIST NOT EXHAUSTIVE）

第12章 付録

Overview

The global holter analysis system & software market reached US$ 1.24 billion in 2023 and is expected to reach US$ 2.84 billion by 2031, growing at a CAGR of 10.9% during the forecast period 2024-2031.

The Holter Analysis System is a medical tool that continuously monitors the heart's electrical activity over 24 to 48 hours. It captures real-time ECG data through electrodes on the patient's chest, identifying and analyzing cardiac irregularities that may not be detected during standard ECGs. Modern Holter systems, developed by Hillrom and Philips, use advanced software for data analysis and reporting, allowing healthcare providers to import recordings from remote sites and export electronic reports securely, ensuring compliance with HIPAA regulations. Notable features include scanning modes, bidirectional interfaces, and sophisticated signal processing algorithms for improved diagnostic accuracy.

Market Dynamics: Drivers & Restraints

Growing Integration with Wearable Component

The global holter analysis system and software market is driven by the increasing integration with wearable Component. Health-conscious consumers are increasingly using wearable devices for fitness and health monitoring, which enhances the user experience by allowing patients to monitor their heart health alongside other health metrics. This convergence not only increases the visibility of Holter monitoring systems in the digital health ecosystem but also promotes greater patient engagement and adherence to monitoring protocols. As patients become more proactive in managing their health, the demand for advanced Holter monitoring solutions is expected to rise, driving market growth.

For instance, in August 2024, iRhythm Technologies, a leading digital health care company, has launched its Zio monitor and long-term continuous (LTCM) ambulatory ECG monitoring service in Austria, the Netherlands, Spain, and Switzerland. The Zio monitor and ZEUS system received CE Marking Under Medical Device Regulation in December 2023. The LTCM service offers up to 14 days of continuous, uninterrupted ECG monitoring, a significant advancement in these countries compared to older Holter monitoring services.

Low Reimbursement Policies

The global Holter Analysis System and Software market faces a significant challenge due to low reimbursement policies for Holter monitoring procedures. In many regions, particularly in developing countries, insurance coverage for Holter monitoring is limited or non-existent, creating financial barriers for healthcare providers and patients. This discourages the adoption of Holter monitoring systems, leading many facilities to opt for less costly alternatives or traditional methods. The financial constraints necessitate a reevaluation of the Holter monitoring system's value proposition to ensure its recognition as essential for effective cardiac care and management.

For more details on this report - Request for Sample

Segment Analysis

The global holter analysis system & software market is segmented based on product type, component, application, end user and region.

Product type:

Wireless Holter Monitor segment is expected to dominate the holter analysis system & software market share

The wireless holter monitor segment holds a major portion of the holter analysis system & software market share and is expected to continue to hold a significant portion of the holter analysis system & software market share during the forecast period.

Surgical instruments are essential tools for various medical procedures, including routine surgeries and complex interventions. They ensure precision, efficiency, and safety. The increasing prevalence of chronic diseases and the number of surgical procedures worldwide have driven the demand for high-quality, specialized instruments. Technological advancements, such as titanium and stainless steel integration, have improved the durability, sterility, and ergonomics of these instruments. Disposable surgical instruments have also addressed concerns about cross-contamination and infection control. The focus on improving surgical outcomes and reducing patient recovery times has further highlighted the importance of surgical instruments in the Holter Analysis System & Software market.

For instance, in September 2022, Borsam Biomedical Instruments has introduced its wireless ECG monitors, the 'Wireless ECG Monitor Event Recorder' and 'ECG Holter Recorder', which allow individuals to monitor their heart health remotely from the hospital. The Event Recorder records ECG data while the Holter is designed for longer-term wear and attaches to the chest using stickers and three leads.

End User:

Hospitals segment is the fastest-growing segment in holter analysis system & software market share

The hospitals segment is the fastest-growing segment in the holter analysis system & software market share and is expected to hold the market share over the forecast period.

Hospitals are the primary users of holter analysis system and software. They are increasingly focusing on preventive cardiology initiatives to address the increasing prevalence of cardiovascular diseases. Holter monitoring systems are crucial for this, providing continuous data collection for early detection and management of cardiac abnormalities. This proactive approach enhances patient outcomes and optimizes treatment plans. Hospitals have advanced infrastructure and technology that facilitate the integration of Holter monitoring systems into clinical workflows, improving diagnostic accuracy and streamlining patient data management. This solidifies hospitals' central role in driving Holter monitoring solutions in the evolving healthcare landscape.

Geographical Analysis

North America is expected to hold a significant position in the holter analysis system & software market share

North America holds a substantial position in the holter analysis system & software market and is expected to hold most of the market share.

Among the factors propelling the holter analysis system and software market in North America is the increasing prevalence of cardiovascular diseases (CVDs) among their aging populations. Indeed, North America records one of the highest incidences of heart conditions and thus the necessity for improved monitoring for early detection and management. Additionally, Increased acceptance of remote monitoring technologies has emerged, as both patients and healthcare professionals seek more convenient ways to take care of and manage health problems instead of confined hospital settings. Modernization and sophistication have characterized the advancements with Holter monitoring devices in technical terms. Consequently, North America is set to maintain a stronghold in the market due to continued investment in healthcare infrastructure and innovation.

For instance, in May 2024, Vivalink, a leading provider of digital healthcare solutions, has launched a technology solution for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution integrates remote patient monitoring technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care. This integration aims to reduce the cost of ambulatory cardiac monitoring services by streamlining delivery and enhancing patient care.

Europe is growing at the fastest pace in the holter analysis system & software market

Europe holds the fastest pace in the holter analysis system & software market and is expected to hold most of the market share.

As life expectancy in various European countries increases, so does the number of health issues, especially those related to the heart, which require regular monitoring because of their age. According to the statistics presented by the European Union, the older population of 65 years and above comprises a significant share of its population. This translates into a growing demand for improved cardiac monitoring solutions like Holter systems. The modernization of healthcare facilities and improved service delivery in several European countries further enhance the availability and effectiveness of Holter monitoring technologies. The above considers changes in the demographical domain, however, growth in the market is witnessed by several challenges-for example, a shortage of skilled human resources to conduct accurate ECG analysis.

For instance, in November 2024, the medilogFD is a new SCHILLER 12-lead Holter ECG for spatial heart health analysis, offering a comprehensive assessment of cardiac ECG conditions. It detects atrial fibrillation/atrial flutter based on true P-wave analysis and can also provide additional respiratory information through the optional SpO2 sensor.

Competitive Landscape

The major global players in the holter analysis system & software market include GE Healthcare, Philips Healthcare, VitalConnect, Vivalink, Cardioline SpA, Schiller AG, Midmark Corporation, Nasiff Associates, Inc., Biomedical Instruments Co., Ltd., iRhythm Technologies, Inc. among others.

Emerging Players

The emerging players in the holter analysis system & software market include LifeSignals, Inc, Bardy Diagnostics, Inc and among others.

Key Developments

• In February 2024, UltraLinQ has launched its Holter Program during American Heart Month, featuring the UbiqVue Holter and ECG Interpretation Software. This innovative biosensor is designed to meet the needs of modern cardiology practices, making cardiac care seamless, accessible, and scalable. The Holter device and software are designed to manage ECG data and final reports.

Why Purchase the Report?

• Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
• Market Positioning: Analysis of product performance and growth potential for optimized strategies.
• Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
• Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
• Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
• Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
• Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
• Market Expansion: Strategies for entering new markets and forming partnerships.
• Regional Opportunities: Identification of high-growth regions and investment prospects.
• Supply Chain Optimization: Assessment of risks and distribution strategies.
• Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
• Post-Market Surveillance: Enhanced safety and access through post-market data.
• Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global holter analysis system & software market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Integration with Wearable Component
• 4.2. Restraints
  • 4.2.1.1. Low Reimbursement Policies
• 4.3. Opportunity
  • 4.3.1. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
  • 6.1.2. Market Attractiveness Index, By Product type
• 6.2. Wireless Holter Monitors*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Wired Holter Monitors
• 6.4. Portable Holter Monitors
• 6.5. Ambulatory ECG Monitors

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Arrhythmia*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Atrial Fibrillation
• 7.4. Bradycardia and Tachycardia
• 7.5. Ischemic Heart Disease
• 7.6. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory Surgical Centers (ASCs)
• 8.4. Cardiac Centers
• 8.5. Clinics
• 8.6. Home Care Settings

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. GE Healthcare*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Philips Healthcare
• 11.3. VitalConnect
• 11.4. Vivalink
• 11.5. Cardioline SpA
• 11.6. Schiller AG
• 11.7. Midmark Corporation
• 11.8. Nasiff Associates, Inc.
• 11.9. Biomedical Instruments Co., Ltd
• 11.10. iRhythm Technologies, Inc. (LIST NOT EXHAUSTIVE)

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us